Oman to fast-track approval of Indian pharma products registered by US FDA, UKMHRA, EMA

12 May 2022 | News

A 48-member delegation comprising senior officials and business leaders from Oman are currently visiting India

Image Credit: PIB

Image Credit: PIB

The 10th Session of the India-Oman Joint Commission Meeting (JCM) discussed on fast tracking of approvals for the registration of Indian pharmaceutical products already registered by US FDA, UKMHRA and EMA.


The meeting was co-chaired by Piyush Goyal, Union Minister of Commerce & Industry, Consumer Affairs, Food & Public Distribution and Textiles, Government of India and Qais bin Mohammed al Yousef, Minister of Commerce, Industry and Investment Promotion of the Sultanate of Oman, who is in India now with a 48-member delegation comprising senior officials and business leaders.


A joint release of a Market Research Report commissioned by the Embassy of India, Muscat on the pharmaceutical sector in Oman highlighted strategies and opportunities for Indian companies in Oman in this sector.


Discussions were held on all Memorandum of Understanding (MoUs)/ Agreements under discussion, including standards and metrology, India-Oman Double Taxation Avoidance Agreement, India-Oman Bilateral Investment Treaty, Invest Oman and Invest India, and Rupay card acceptance in Oman etc.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account